These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21115382)

  • 1. [In Vitro Fertilization: beware of oocyte retrieval without oocyte!].
    Bringer-Deutsch S; Mayenga JM; Grefenstette I; Grzegorczyk V; Kulski O; Belaisch-Allart J
    Gynecol Obstet Fertil; 2010 Nov; 38(11):690-2. PubMed ID: 21115382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
    Quaas AM; Missmer SA; Ginsburg ES
    Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of automated follicle monitoring in 58 in vitro fertilization cycles: follicular volume as a new indicator of oocyte maturity.
    Rodríguez-Fuentes A; Hernández J; García-Guzman R; Chinea E; Iaconianni L; Palumbo A
    Fertil Steril; 2010 Feb; 93(2):616-20. PubMed ID: 19376513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue hCG to treat empty follicle syndrome after the use of a GnRH agonist as oocyte maturation trigger: First report on fresh embryo transfer and clinical pregnancy.
    Christopoulos G; Vlismas A; Barsoum-Derias E; El-Shawarby S; Trew G; Lavery S
    Hum Fertil (Camb); 2015; 18(4):248-52. PubMed ID: 26400626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of follicular fluid human chorionic gonadotrophin level with oocyte maturity and early embryonic development].
    Zhang L; Wang H; Zhang R; Liang J; Liu C; Zhou Y; Wen A
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):260-4. PubMed ID: 24589609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes.
    Zilberberg E; Haas J; Dar S; Kedem A; Machtinger R; Orvieto R
    Gynecol Endocrinol; 2015 Feb; 31(2):145-7. PubMed ID: 25385007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
    Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation.
    Kolibianakis E; Zikopoulos K; Camus M; Tournaye H; Van Steirteghem A; Devroey P
    Hum Reprod; 2004 Nov; 19(11):2545-9. PubMed ID: 15471941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome.
    Li X; Zeng C; Shang J; Wang S; Gao XL; Xue Q
    Chin Med J (Engl); 2019 May; 132(10):1194-1201. PubMed ID: 30973445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonging oocyte in vitro culture and handling time does not compensate for a shorter interval from human chorionic gonadotropin administration to oocyte pickup.
    Garor R; Shufaro Y; Kotler N; Shefer D; Krasilnikov N; Ben-Haroush A; Pinkas H; Fisch B; Sapir O
    Fertil Steril; 2015 Jan; 103(1):72-5. PubMed ID: 25439844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program.
    Bianchi V; Dal Prato L; Maccolini A; Mazzone S; Borini A
    Fertil Steril; 2009 Nov; 92(5):1747.e1-3. PubMed ID: 19732874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study.
    Weiss A; Neril R; Geslevich J; Lavee M; Beck-Fruchter R; Golan J; Shalev E
    Fertil Steril; 2014 Aug; 102(2):419-23. PubMed ID: 24880653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a pre-retrieval serum human chorionic gonadotrophin (hCG) threshold level for prediction of subsequent retrieval outcomes and pregnancy in fresh ICSI cycles?
    Vishnevsky G; Shoham Z; Or Y
    Gynecol Endocrinol; 2020 Jul; 36(7):641-645. PubMed ID: 31847630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity.
    Rapi S; Fuzzi B; Mannelli M; Pratesi S; Criscuoli L; Pellegrini S; Messeri G
    Acta Eur Fertil; 1992; 23(2):63-8. PubMed ID: 1338258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
    Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
    Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failed oocyte retrieval in in-vitro fertilization with documented positive serum beta-human chorionic gonadotrophin (HCG) concentration on day HCG+1.
    Traina V; Boyer P; Piccinni O; Costantino G; D'Amato G; D'Addario V; Cho YS
    Hum Reprod; 1993 Nov; 8(11):1854-5. PubMed ID: 7507129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.